Bioventus Inc.BVSNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank93
3Y CAGR+73.4%
Studio
Year-over-Year Change

Year-over-year net income growth rate

3Y CAGR
+73.4%/yr
vs -31.8%/yr prior
Acceleration
+105.2pp
Accelerating
Percentile
P93
Near historical high
vs 3Y Ago
5.2x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
PeriodValue
Q4 2025367.67%
Q3 2025-57.70%
Q2 2025382.86%
Q1 2025-1590.38%
Q4 202496.77%
Q3 202481.22%
Q2 2024-425.19%
Q1 202419.78%
Q4 202316.53%
Q3 2023-98.40%
Q3 202397.35%
Q2 2023-335.80%
Q4 202270.50%
Q4 2022-1392.62%
Q3 202235.69%
Q2 2022-2998.08%
Q4 202166.01%
Q4 202174.04%
Q3 2021-116.55%
Q2 2021798.27%
Q4 2020-67.18%
Q3 2020246.67%
Q2 2020-152.69%
Q1 202094.15%
Q4 201935.67%
Q3 2019244.62%
Q2 20190.00%
Q1 20190.00%
Q1 20160.00%
Q1 20150.00%